
Appointment Information
Albert Lea, MN
Hospital and Clinic
404 W. Fountain St., Albert Lea, MN 56007Rochester, MN
Fountain Centers
4122 18th Ave. NW, Rochester, MN 55901Provider's Bio
I'm a medical oncologist with a focus in gastrointestinal cancers. I have focused on developing novel therapies for patients with liver and bile duct cancers, as well as patients with metastases to the liver from colorectal cancer.
I serve as the chair of the Division of Medical Oncology and as deputy director for Clinical Research in the Mayo Clinic Comprehensive Cancer Center.
Training & Credentials
Medical School
- University of Washington School of Medicine
Residency
- Internal Medicine, Mayo Clinic College of Medicine and Science
Fellowships
- Hematology, Mayo Clinic College of Medicine and Science
- Oncology, Mayo Clinic College of Medicine and Science
- Internal Medicine, Mayo Clinic College of Medicine and Science
Certification
- Medical Oncology, American Board of Internal Medicine
Memberships
- Alliance for Clinical Trials in Oncology
- Alliance Foundation Trials
- Mayo Clinic Comprehensive Cancer Center, Office of Research Information Services
Academic Appointment
- Professor of Oncology, Mayo Clinic College of Medicine and Science
Special Interests
- Anal cancer
- Cholangiocarcinoma
- Colon cancer
- Esophageal cancer
- Gallbladder cancer
- Hepatocellular carcinoma
- Liver cancer
- Neuroendocrine tumor
- Pancreatic cancer
- Rectal cancer
- Small bowel cancer
- Stomach cancer
Research & Publications
- Impact of diabetes and metformin use on recurrence and outcome in state II-III colon cancer patients - A pooled analysis of three adjuvant trials, May 2022
- N064A (Alliance): Phase II study of panitumumab, chemotherapy, and external beam radiation in patients with locally advanced pancreatic adenocarcinoma, March 2022
- Reevaluating disease-free survival as an endpoint vs. overall survival in Stage III adjuvant colon cancer trials, January 2022
- A genome-wide search for determinants of survival in 1926 patients with advanced colorectal cancer with follow-up in over 22,000 patients, December 2021
- FGFR inhibitor toxicity and efficacy in cholangiocarcinoma: Multicenter single-institution cohort experience, July 2021